From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research
University of California San Diego · VA San Diego Healthcare System · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
126
total citations
- FWCI
- 44.89
- Percentile
- 100%
- References
- 15
Citations per year
Authors
2Topics & keywords
Topics
Keywords
- Insulin resistance
- Fatty liver
- Medicine
- Disease
- Metabolic syndrome
- Obesity
- Liver disease
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- AAAmerican Association for the Study of Liver DiseasesAward: CTORA23-208366
- NINational Institutes of HealthAwards: R01DK106419, P30DK120515, U01DK130190, 5UL1TR001442, U01DK061734, P50AA011999
- NINational Institute on Alcohol Abuse and AlcoholismAwards: K99AA031328, P50AA011999
- NHNational Heart, Lung, and Blood InstituteAwards: P30DK120515, P01HL147835
- NINational Institute of Diabetes and Digestive and Kidney DiseasesAwards: R01DK121378, P30DK120515, U01DK061734, U01DK130190, R01DK106419, R01DK124318
- NINational Institute of Environmental Health SciencesAward: 5P42ES010337
- NCNational Center for Advancing Translational SciencesAwards: U01DK061734, U01DK130190, P30DK120515, R01DK121378, 5UL1TR001442, R01DK124318, R01DK106419